Ortho Clinical Diagnostics (OCDX) PT Raised to $27 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts OCDX Hot Sheet
Price: $17.63 --0%
Rating Summary:
7 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 16
Rating Summary:
7 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 16
Join SI Premium – FREE
Barclays analyst Luke Sergott raised the price target on Ortho Clinical Diagnostics (NASDAQ: OCDX) to $27.00 (from $24.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Intrepid Potash (IPI) PT Lowered to $41 at Freedom Broker
- TFI International Inc. (TFII:CN) (TFII) PT Lowered to Cdn$211 at Goldman Sachs
- Kinross Gold (K:CN) (KGC) PT Lowered to Cdn$45 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
